Completed PHASE2 INTERVENTIONAL 3-arm NCT02046980

Treatment of Apogeotropic Horizontal Canal Benign Paroxysmal Positional Vertigo

Sponsor: Keimyung University Dongsan Medical Center

Conditions Benign Paroxysmal Positional Vertigo

Updated 8 times since 2017 Last updated: Feb 12, 2016 Started: Sep 30, 2013 Primary completion: Jul 31, 2015 Completion: Jul 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02046980, this PHASE2 trial focuses on Benign Paroxysmal Positional Vertigo and remains completed. Sponsored by Keimyung University Dongsan Medical Center, it has been updated 8 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE2
Sep 2024 — Sep 2025 [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2023 — Jul 2024 [monthly]

Completed PHASE2
Dec 2022 — Jan 2023 [monthly]

Completed PHASE2

▶ Show 3 earlier versions

Jan 2021 — Dec 2022 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Sep 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Keimyung University Dongsan Medical Center

Data source: Keimyung University Dongsan Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Daegu, South Korea